CREATIVE MEDICAL TECHNOLOGY (CELZ) Stock Analyst Ratings
NASDAQ:CELZ - Nasdaq - US22529Y4089 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to CELZ. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 26.52. This target is 960.8% above the current price.
CELZ was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CELZ.
In the previous month the buy percentage consensus was at a similar level.
CELZ was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-02-25 | Roth Capital | Initiate | Buy |